Literature DB >> 28848857

The COPD Pipeline XXIX.

Nicholas Gross1,2.   

Abstract

Keywords:  COPD biomarker; COPD clinical research; GSK2269557; Glassia; Lebrikizumab; Orkambi; PT010; PneumRx; RNS60; Stiolto Respimat; TD-4208

Year:  2015        PMID： 28848857      PMCID： PMC5556831          DOI： 10.15326/jcopdf.2.4.2015.0163

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  3 in total

1.  The COPD pipeline.

Authors:  Yasser Mushtaq
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

2.  Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

Authors:  Peter Norman
Journal:  Expert Opin Ther Pat       Date:  2014-12       Impact factor: 6.674

3.  Compliance with results reporting at ClinicalTrials.gov.

Authors:  Monique L Anderson; Karen Chiswell; Eric D Peterson; Asba Tasneem; James Topping; Robert M Califf
Journal:  N Engl J Med       Date:  2015-03-12       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.